In vitro evaluation of poly(ε-caprolactone-co-DL-lactide)/bioactive glass composites
Source abstract
Abstract
In vitro bioactivity of composites of poly(epsilon-caprolactone-co-DL-lactide) P(CL/DL-LA) containing different amounts (40, 60 and 70 wt%) of bioactive glass, S53P4, was evaluated. Two ranges of granule size of bioactive glass (< 45 microm and 90-315 microm) were blended with P(CL/DL-LA) copolymer in a batch mixer. The composites were characterised by dynamic mechanical thermal analysis. The molecular weight and the melting temperature of the copolymer matrix were adjusted to enable the application of the composite material by injection below 50 degrees C. Formation of Ca-P deposition on the surface of the composites after dissolution in simulated body fluid at 37 degrees C was recorded by scanning electron microscopy. Degradation of the composite material was measured by water absorption and changes in the average molecular weights as a function of the dissolution time. In vitro bioactivity was found to be dependent on the weight fraction and granule size range of the bioactive glass used. The presence of the bioactive filler also accelerated the degradation compared with the neat polymer sample.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Orthodontics and Dentofacial Orthopedics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (32)
Show source-provided references
1. Degradable implant materials10.1016/S0267-6605(86)80015-4 ↗
2. Bioresorbable and Bioerodible Materials
3. Poly ε-caprolactone and its copolymers
4. Polymerization temperature effects on the properties of l-lactide and ε-caprolactone copolymers10.1007/BF00316903 ↗
5. Synthesis, characterization and miscibility of caprolactone random copolymers10.1021/ma00161a009 ↗
6. Biodegradable lactone copolymers I. Characterization and mechanical behavior of ε-caprolactone and lactide copolymers10.1002/(SICI)1097-4628(19960222)59:8<1281::AID-APP11>3.0.CO;2-9 ↗
7. Aliphatic polyesters. I. The degradation of poly(ε-caprolactone) in vivo10.1002/app.1981.070261124 ↗
8. Aliphatic polyesters. II. The degradation of poly(DL-lactide), poly(ε-caprolactone), and their copolymers in vivo10.1016/0142-9612(81)90060-0 ↗
9. Bonding mechanisms at the interface of ceramic prosthetic materials10.1002/jbm.820050611 ↗
10. Ca, P-rich layer formed on high-strength bioactive glass-ceramic A-W10.1002/jbm.820240306 ↗
11. In vivo behaviour of glasses in the SiO2–Na2O–CaO–P2O5–Al2O3–B2O3 system10.1007/BF00701080 ↗
12. Compositional dependence of bioactivity of glasses in the system Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO210.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G ↗
13. Mechanishm of apatite formation on CAO-SiO2-P2O5 glasses in a simulated body fluid10.1016/S0022-3093(05)80556-3 ↗
14. A structural approach to bone adhering of bioactive glasses10.1016/0022-3093(89)90495-X ↗
15. Surface chemistry of bioactive glass-ceramics10.1016/0022-3093(90)90199-V ↗
16. Effect of calcium phosphate coating characteristics on early post-operative bone tissue ingrowth10.1016/0142-9612(90)90073-Y ↗
17. Calcium and phosphate supplementation promotes bone cell mineralization10.1002/1097-4636(200011)52:2<270::AID-JBM5>3.0.CO;2-1 ↗
18. Polymer-hydroxyapatite composites for biodegradable bone fillers10.1016/0142-9612(86)90099-2 ↗
19. Histological evaluation of a bioderadable polyactive®/hydroxyapatite membrane10.1016/0142-9612(95)94142-8 ↗
20. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
21. In vitro evaluation of biodegradable å-caprolactone-co-D,L-lactide/silica xerogel composites containing toremifene citrate10.1016/S0378-5173(99)00022-8 ↗
22. Self-reinforced glass-bioresorbable polymer composites10.1557/PROC-550-267 ↗
23. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W310.1002/jbm.820240607 ↗
24. Synthesis of polylactide in the presence of co-initiators with different numbers of hydroxyl groups10.1016/S0032-3861(01)00150-1 ↗
25. Bioactive glass granules and plates in the reconstruction of defects of the facial bones10.3109/02844319609056406 ↗
26. Obliteration of the frontal sinus cavity with bioactive glass10.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-1 ↗
27. Turunen T, Peltola J, Yli-Urpo A, Happonen RP. Bioactive glass granules as a bone substitute material in connection with maxillary sinus floor augmentation. Clin Oral Impl Res, submitted for publication.
28. Dynamic-mechanical properties
29. Sustained drug delivery systems. I. The permeability of poly(ε-caprolactone), poly(DL-lactide) and their copolymers10.1002/jbm.820130313 ↗
30. New bioactive, degradable composite microspheres as tissue engineering substrates10.1002/1097-4636(200010)52:1<66::AID-JBM9>3.0.CO;2-2 ↗
31. In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite10.1016/0142-9612(91)90072-I ↗
32. Jaakkola T, Tirri T, Rich J, Seppälä J, Närhi T, Yli-Urpo A. In vitro apatite formation on biodegradable thermoplastic composite of poly(ε-caprolactone-co-DL-lactide) and bioactive glass. Biomaterials, submitted for publication.